The company's promoters, Chetan Sandesara and Nitin Sandesara, are absconding and believed to be in Africa.

The absconding promoters of the Sterling group-- Nitin and Chetan Sandesara--are alleged to have defrauded over Rs 14,500 crore of public m...

“The tribunal has decided to refer the company for insolvency in a verbal order,” said one of the people.

The NCLT bench presided over by VP Singh and Ravikumar Duraisamy also asked the bond holders of Madison Pacific Trust, who is opposing the ...

The tribunal also excluded the litigation time from the bankruptcy process until further orders.

The Mumbai bench of the National Company Law Tribunal on Thursday gave 24 hours to the committee of creditors (CoC) to file its response.

Nitin and Chetan Sandesara are absconding and are believed to be abroad and are facing a Delhi court trail to declare them fugitive economi...

The Mumbai-bench of NCLT on Friday stayed its earlier order after the Ministry of Corporate Affairs informed the tribunal that a similar wi...

Gujarat-based Sterling SEZ is a subsidiary of Sterling Group that owes over Rs 8,100 crore to its financial and operational lenders.

Tribunal directing ED to release firm’s assets attached under PMLA may help creditors take legal route.

On October 23, the ED filed a supplementary chargesheet against seven persons in the court in the money laundering case.

Last October, the CBI registered a criminal case against Sterling Biotech, its directors and a then director of Andhra Bank for allegedly c...

As part of the restructuring plan, fresh zero coupon convertible bonds will be issued to replace existing bonds.

SEZs have emerged as a major source of exports as they contributed 35 per cent in the country's shipments in 2009-10.

Sterling SEZ, the brainchild of industrial heavyweights Sandesara Group, is one of the largest multi-product SEZs in India currently spread...

Sterling Biotech is planning to set up a multi-product Special Economic Zone (SEZ) at Jambusar in Gujarat, with a proposed investment of Rs...

The Rs 220-crore Dishman Pharmaceuticals & Chemicals, one of the leading active pharmaceutical ingredient makers in India, is planning to d...